These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10593326)

  • 1. Analysis of aminoglycosides in the treatment of gram-negative infections in surgical patients.
    Crabtree TD; Pelletier SJ; Gleason TG; Pruett TL; Sawyer RG
    Arch Surg; 1999 Dec; 134(12):1293-8; discussion 1298-9. PubMed ID: 10593326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of antibiotic-resistant Gram-negative bacilli infections on outcome in hospitalized patients.
    Raymond DP; Pelletier SJ; Crabtree TD; Evans HL; Pruett TL; Sawyer RG
    Crit Care Med; 2003 Apr; 31(4):1035-41. PubMed ID: 12682469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices.
    Kollef MH; Ward S; Sherman G; Prentice D; Schaiff R; Huey W; Fraser VJ
    Crit Care Med; 2000 Oct; 28(10):3456-64. PubMed ID: 11057801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategy of antibiotic rotation: long-term effect on incidence and susceptibilities of Gram-negative bacilli responsible for ventilator-associated pneumonia.
    Gruson D; Hilbert G; Vargas F; Valentino R; Bui N; Pereyre S; Bebear C; Bebear CM; Gbikpi-Benissan G
    Crit Care Med; 2003 Jul; 31(7):1908-14. PubMed ID: 12847382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Waiting for microbiologic data to direct therapy against nosocomial infections in febrile surgical patients: are outcomes worsened?
    Pelletier SJ; Crabtree TD; Gleason TG; Banas LE; Patel SR; Pruett TL; Sawyer RG
    Arch Surg; 1999 Dec; 134(12):1300-7; discussion 1307-8. PubMed ID: 10593327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality.
    Lacy MK; Stryjewski ME; Wang W; Hardin TC; Nogid B; Luke DR; Shorr AF; Corey GR; Barriere SL
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S87-93. PubMed ID: 26316562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of multidrug resistance on the outcomes of critically ill patients with Gram-negative bacterial pneumonia.
    Kwa AL; Low JG; Lee E; Kurup A; Chee HL; Tam VH
    Diagn Microbiol Infect Dis; 2007 May; 58(1):99-104. PubMed ID: 17300905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Nosocomial pneumonia].
    Syrjälä H
    Duodecim; 1996; 112(10):913-23. PubMed ID: 10592983
    [No Abstract]   [Full Text] [Related]  

  • 9. Restriction of third-generation cephalosporin use decreases infection-related mortality.
    Du B; Chen D; Liu D; Long Y; Shi Y; Wang H; Rui X; Cui N
    Crit Care Med; 2003 Apr; 31(4):1088-93. PubMed ID: 12682477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
    Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of late-onset hospital-acquired pneumonia related to causative organism.
    McClure JR; Cooke RP; Lal P; Pickles D; Majjid S; Grant CA; Jones TM; Dempsey GA
    J Hosp Infect; 2009 Apr; 71(4):348-52. PubMed ID: 19157643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis].
    Iakovlev SV; Beloborodov VB; Sidorenko SV; Iakovlev VP; Grigor'ev KB; Eliseeva EV; Kon EM; Levit AL; Kostina GV; Kuprenkov AV; Mukhacheva SIu; Saturnov AV; Sergeev IN; Spasov GP; Stakanov AV; Ushakova MA
    Antibiot Khimioter; 2006; 51(7):15-27. PubMed ID: 18035730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.
    Kollef MH; Ward S
    Chest; 1998 Feb; 113(2):412-20. PubMed ID: 9498961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cephalosporin therapeutics for intensive care infections.
    Salacata A; Chow JW
    New Horiz; 1993 May; 1(2):181-6. PubMed ID: 7922401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risk factors and prognosis of nosocomial pneumonia due to gram-negative bacteria in a general hospital].
    Martínez B; Gómez J; Gómez Vargas J; Gómez JR; Baños V; Sánchez ME; Canteras M; Valdés M
    Rev Esp Quimioter; 2000 Jun; 13(2):187-92. PubMed ID: 10918093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing aminoglycoside therapy for nosocomial pneumonia caused by gram-negative bacteria.
    Kashuba AD; Nafziger AN; Drusano GL; Bertino JS
    Antimicrob Agents Chemother; 1999 Mar; 43(3):623-9. PubMed ID: 10049277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset pneumonia after liver transplantation: microbiological findings and therapeutic consequences.
    Weiss E; Dahmani S; Bert F; Janny S; Sommacale D; Dondero F; Francoz C; Belghiti J; Mantz J; Paugam-Burtz C
    Liver Transpl; 2010 Oct; 16(10):1178-85. PubMed ID: 20879016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in nosocomial pneumonia in surgical patients as we approach the 21st century: a prospective analysis.
    Crabtree TD; Gleason TG; Pruett TL; Sawyer RG
    Am Surg; 1999 Aug; 65(8):706-9; discussion 710. PubMed ID: 10432077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia.
    Mohr AM; Sifri ZC; Horng HS; Sadek R; Savetamal A; Hauser CJ; Livingston DH
    Surg Infect (Larchmt); 2007 Jun; 8(3):349-57. PubMed ID: 17635058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective audit of costs and outcome of aminoglycoside treatment and of therapy for gram-negative bacteraemia.
    Davey PG; Parker SE; Orange G; Malek M; Dodd T
    J Antimicrob Chemother; 1995 Sep; 36(3):561-75. PubMed ID: 8830023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.